Cargando…

Risk of Developing Alzheimer’s Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up

BACKGROUND: There is no any large randomized clinical trial of antihypertensive drug treatment with 18-year passive follow-up to examine the risk of Alzheimer’s Disease (AD) or Related Dementias (ADRD). METHODS: Post-trial passive follow-up study of Antihypertensive and Lipid-Lowering Treatment to P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xianglin L., Simpson, Lara M., Osani, Mikala C., Yama, Jose-Miguel, Davis, Barry R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095428/ https://www.ncbi.nlm.nih.gov/pubmed/35571234

Ejemplares similares

Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker
por: Du, Xianglin L., et al.
Publicado: (2021)

Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial
por: Yamal, Jose-Miguel, et al.
Publicado: (2023)

The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT–Medicare linked data
por: Du, Xianglin L., et al.
Publicado: (2023)

Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended
por: Du, Xianglin L., et al.
Publicado: (2021)

Comments on ALLHAT and doxazosin
por: Krakoff, Lawrence R
Publicado: (2001)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review
por: Brewster, Lizzy M, et al.
Publicado: (2013)

Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT
por: Shahu, Andi, et al.
Publicado: (2019)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Impact of the ALLHAT Study Results on Managed Care
por: Anderson, Robert J.
Publicado: (2003)

Diuretic and β-Blocker in Hypertension—Then What?
por: Ramsay, L. E.
Publicado: (1980)

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
por: Piller, Linda B, et al.
Publicado: (2002)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid-lowering component of ALLHAT
por: Rahman, Mahboob, et al.
Publicado: (2013)

A new era in hypertension research: discussing the findings of ALLHAT
por: Furberg, Curt D
Publicado: (2001)

Prevention of Heart Failure in Hypertension—Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study
por: Johnson, Kyle, et al.
Publicado: (2019)

Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
por: Osani, Mikala C., et al.
Publicado: (2019)

Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2012)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe, Massimo, et al.
Publicado: (2012)

Renal outcomes of diabetic patients treated with combination therapy of ACE inhibitors plus either thiazide diuretics or calcium channel blockers: comparative retrospective cohort study in Northwestern Ethiopia
por: Netere, Adeladlew Kassie, et al.
Publicado: (2021)

Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker–Induced Lower-Extremity Edema With Loop Diuretics
por: Vouri, Scott Martin, et al.
Publicado: (2019)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2013)

Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis
por: Desai, Niraj, et al.
Publicado: (2020)

Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study
por: Harrison, Paul J, et al.
Publicado: (2020)

Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis on the Risks Associated with Triple Whammy
por: Mattioli, Irene, et al.
Publicado: (2023)

Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
por: Gavras, Irene, et al.
Publicado: (2001)

Antihypertensive Drug Effects on Renal Function and Myocardial Infarction and Implications of the ALLHAT Study Results
por: Curtiss, Frederic R.
Publicado: (2003)

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial(1)
por: Ogihara, Toshio, et al.
Publicado: (2014)

Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability
por: Saruta, Takao, et al.
Publicado: (2015)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis
por: Cheng, Yiming, et al.
Publicado: (2016)

Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
por: Hooper, Philip L
Publicado: (2001)

Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production
por: Lovell, Mark A., et al.
Publicado: (2015)

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial
por: Ogihara, Toshio, et al.
Publicado: (2015)

Diuretic Use Among Patients Receiving Hemodialysis in the United States
por: Flythe, Jennifer E., et al.
Publicado: (2022)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Enteral Sodium Chloride Supplementation and Fluid Balance in Children Receiving Diuretics
por: Ortmann, Laura, et al.
Publicado: (2022)

Calcium Channel Blocker-Associated Chyloperitoneum in Patients Receiving Peritoneal Dialysis: A Systematic Review
por: Kim, Seungyeon, et al.
Publicado: (2019)

Diuretics
por: Alstead, Stanley
Publicado: (1933)

Cannot write session to /tmp/vufind_sessions/sess_kq34n4sqf56ck6lalkjqutbfol